The HCPLive Geriatric medicine condition center page is a comprehensive resource for clinical news and insights on frequent geriatric-related diseases and conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for sleep disorder, dementia, Alzheimer's disease, and more.
April 02, 2025
Article
The FDA granted fast-track status to Biogen’s BIIB080, a tau-targeting therapy for Alzheimer Disease, which is now being evaluated in the global phase 2 CELIA study.
February 22, 2025
Article
Our top 5 headlines included a new approval for atopic dermatitis, expert consensus on anaphylaxis care, and the end of the semaglutide shortage.
February 07, 2025
Article
More than 90% of patients with hemophilia B eliminated factor IX prophylaxis 4 years after treatment with etranacogene dezaparvovec (HEMGENIX) gene therapy.
February 06, 2025
Article
SGLT2 inhibitors lower the risk of MACE in older age, despite smaller HbA1c reductions, while GLP-1 RAs were more cardioprotective in younger individuals with T2D.
February 05, 2025
Article
This Month in Review highlights the top psychiatry news in January.
February 03, 2025
Video
HCPLive spoke with Sachs about his study on palliative care for dementia, which reduced ED visits but didn’t significantly improve neuropsychiatric symptoms.
February 03, 2025
Article
A study indicated that telomere length may not directly cause age-related brain diseases, but healthier lifestyles could counteract the harmful effects of shorter telomeres.
January 30, 2025
Article
A study showed that greater total cholesterol and low-density lipoprotein cholesterol were associated with a quicker decline in global cognition.
January 30, 2025
Article
A study found palliative care for dementia did not improve neuropsychiatric symptoms but reduced emergency visits and hospitalizations over 2 years.
January 29, 2025
Article
A trial found system- and community-based dementia care had no advantage over usual care, except for improved caregiver self-efficacy at 6 months.